Thiola EC - (100 and 300 mg; Tablet, Delayed release)

Generic Name	Tiopronin	Innovator	Mission Pharmacal
Dosage	100 and 300 mg; Tablet, Delayed release	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	Less Than 5
Indication	THIOLA EC is a reducing and complexing thiol indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 20 kg and greater with severe homozygous cystinuria, who are not responsive to these measures alone
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*** ******	*** \ ***	-**-	*** *********	******** ************	****** **** ********
******	*** \ *********	-**-	*** *********	********	******** ** *** **, ****
*******	** / **	-**-	*** *********	********	******** ** *** **, ****

Chronology Of Events